Di Leo A, Toi M, Campone M, et al. MONARCH 3: Abemaciclib as initial therapy for patients with HR+/HER2- advanced breast cancer. ESMO 2017, abstract 236O_PR.
Grote globale verschillen in implementatie van hypofractionering bij radiotherapie
nov 2018 | Borstkanker, Radiotherapie, Uro-oncologie